548 Episodio

  1. Lessons from Autism on Accelerating Drug Development

    Pubblicato: 24/08/2016
  2. How One Rare Disease Group Leverages Relationships with Industry

    Pubblicato: 17/08/2016
  3. Ice Bucket Challenge Begins to Yield Results

    Pubblicato: 10/08/2016
  4. Why a Common Diabetes Drug May Be Able to Treat a Rare Disease

    Pubblicato: 03/08/2016
  5. How to Improve Patient Access to Experimental Drugs

    Pubblicato: 27/07/2016
  6. Using Social Media to Find Rare Disease Patients for Clinical Trials

    Pubblicato: 20/07/2016
  7. How Rare Disease Patients Weigh Risks and Benefits of a Therapy

    Pubblicato: 13/07/2016
  8. Why Homology Medicines Might Be a Game Changer for Gene Therapy

    Pubblicato: 06/07/2016
  9. Orchard Hopes to Bear the Fruit of Gene Therapy

    Pubblicato: 28/06/2016
  10. Novel Approach to Treat Rare Disease May Lead to Drugs for Common Ones

    Pubblicato: 22/06/2016
  11. Brining Whole Genome Sequencing into the Clinic

    Pubblicato: 15/06/2016
  12. Bringing Patient-Centricity to Clinical Trials

    Pubblicato: 08/06/2016
  13. Determining If a Child's Neurologic or Psychiatric Symptoms are Caused by an Infection

    Pubblicato: 01/06/2016
  14. Making Genetic Data Accessible to Researchers

    Pubblicato: 25/05/2016
  15. How New Sequencing Technology Is Changing Our Understanding of Rare Diseases

    Pubblicato: 18/05/2016
  16. Marathon Readies DMD Drug for FDA

    Pubblicato: 11/05/2016
  17. Searching for Genes They May Protect Against Deadly Diseases

    Pubblicato: 04/05/2016
  18. Helping Patients with the Same Undiagnosed Genetic Condition Find Each Other

    Pubblicato: 27/04/2016
  19. Living with a Disease in Search of a Name

    Pubblicato: 20/04/2016
  20. New Means of Regulating Genes May Hold Promise for Rare Disease Patients

    Pubblicato: 13/04/2016

24 / 28

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.

Visit the podcast's native language site